Upon overexpression of OC2 in NCI-H510 cells, we observe the enrichment of SCLC-Y signature and the upregulation of POU2 F3 together with several other markers of the SCLC-P subtype. This evidence concerns the gene ONECUT2 and small cell lung carcinoma.